◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

HomeAll stocksIESC › EBITDA

IES Holdings Inc (IESC) EBITDA 2006–TTM

DATA UPDATED 2026-09-19

IES Holdings Inc annual ebitda for fiscal 2025 was $442 million, an increase of 28.9% from $343 million in fiscal 2024. All figures are reported results from public filings — no estimates or projections.

IESC Annual EBITDA

EBITDA (annual)TTM → 2026-06-302025-09-302024-09-302023-09-302022-09-302021-09-302020-09-302019-09-302018-09-302017-09-302016-09-302015-09-302014-09-302013-09-302012-09-302011-09-302010-09-302009-09-302008-09-302007-09-302006-09-30
EBITDA$442M$343M$191M$81M$108M$62M$51M$35M$30M$32M$21M$10M$3M$2M($29M)($22M)$1M$28M$18M$11M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

IESC Quarterly EBITDA

EBITDA (quarterly)2026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-302024-06-30
EBITDA$166M$117M$121M$121M$111M$89M$87M$100M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

EBITDA at Comparable Companies

More IESC metrics: Revenue · Gross Profit · Operating Income · Net Income · EPS · Free Cash Flow · Shares Outstanding

All IESC financial statements → Interactive IESC charts →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.